Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 21-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 4 of 4)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
21-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
21-May-13 GlobalData GlobalData Adamis Pharmaceuticals Corporation (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile 25 $250 View Abstract
17-May-13 Reuters Investment Profile N/A Adamis Pharmaceuticals Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
18-Apr-13 GlobalData GlobalData Adamis Pharmaceuticals Corporation (ADMP) - Financial Analysis Review 25 $125 View Abstract

Independent Reports (Showing 1 to 4 of 4)

Release
Date Contributor Author Title Pages Price More Info
21-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
21-May-13 GlobalData GlobalData Adamis Pharmaceuticals Corporation (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile 25 $250 View Abstract
17-May-13 Reuters Investment Profile N/A Adamis Pharmaceuticals Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
18-Apr-13 GlobalData GlobalData Adamis Pharmaceuticals Corporation (ADMP) - Financial Analysis Review 25 $125 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.